Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 375461 - 375480 out of 563794 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Moldova | (J05AX19) tilorone (adm: O) | Lavomax® Neo 125 mg | N6, 125 mg, comprimate filmate, 125 mg , comprimate filmate | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NijfarmSA,Rusia(PROD:HemofarmSRL,Rusia;) |
| Moldova | (J05AX19) tilorone (adm: O) | Lavomax® Neo 125 mg | N3, 125 mg, comprimate filmate, 125 mg , comprimate filmate | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NijfarmSA,Rusia(PROD:HemofarmSRL,Rusia;) |
| Moldova | (J07BD52) measles, combinations with mumps and rubella, live attenuated | Priorix 1 doză | N1 + N1 seringă preumplută cu solvent și cu 2 ace, 1 doză, 0,5ml, pulbere şi solvent pentru soluţie injectabilă, 1 doză , pulbere şi solvent pentru soluţie injectabilă | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GlaxoSmithKlineBiologicalsS.A.,Belgia(PROD:GlaxoSmithKlineBiologicalsS.A.,Belgia;) |
| Moldova | (L01BA01) methotrexate | Metotrexat-BP 100 mg/ml | N1, 100 mg/ml, 5ml, concentrat pentru soluţie perfuzabilă, 100 mg/ml , concentrat pentru soluţie perfuzabilă | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | SCBalkanPharmaceuticalsSRL,RepublicaMoldova(PROD:SCBalkanPharmaceuticalsSRL,RepublicaMoldova;) |
| Moldova | (L01BC03) tegafur | Ftorafur® 400 mg | N100, 400 mg, capsule, 400 mg , capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GrindeksSA,Letonia(PROD:GrindeksSA,Letonia;) |
| Moldova | (L01BC07) azacitidine | Azacitidine Accord 25 mg/ml 100 mg | N1, 100 mg, pulbere pentru suspensie injectabilă, 100 mg , pulbere pentru suspensie injectabilă | Ex-factory price without vat |
$0-0 |
$0-0 |
Myelodysplastic Syndromes;Leukemia, Myelomonocytic, Chronic;Leukemia, Myeloid, Acute | AccordHealthcareS.L.U.,Spania(PROD:AccordHealthcarePolskaSp.z.o.o,Polonia;) |
| Moldova | (L01BC07) azacitidine | Azacitidine Seacross 25 mg/ml 100 mg | N1, 100 mg, pulbere pentru suspensie injectabilă, 100 mg , pulbere pentru suspensie injectabilă | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | SeacrossPharmaceuticalsLimited,MareaBritanie(PROD:SeacrossPharmaceuticalsLimited,MareaBritanie;) |
| Moldova | (L01CD02) docetaxel | Docetaxel 20 mg/ml 20 mg/ml | N1, 20 mg/ml, 1ml, concentrat pentru soluţie perfuzabilă, 20 mg/ml , concentrat pentru soluţie perfuzabilă | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | SeacrossPharmaceuticalsLimited,MareaBritanie(PROD:SeacrossPharmaceuticalsLimited,MareaBritanie;) |
| Moldova | (L01CD02) docetaxel | Docetaxel 20 mg/ml 20 mg/ml | N1, 20 mg/ml, 8ml, concentrat pentru soluţie perfuzabilă, 20 mg/ml , concentrat pentru soluţie perfuzabilă | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | SeacrossPharmaceuticalsLimited,MareaBritanie(PROD:SeacrossPharmaceuticalsLimited,MareaBritanie;) |
| Moldova | (L01CD02) docetaxel | Docetaxel 20 mg/ml 20 mg/ml | N1, 20 mg/ml, 4ml, concentrat pentru soluţie perfuzabilă, 20 mg/ml , concentrat pentru soluţie perfuzabilă | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | SeacrossPharmaceuticalsLimited,MareaBritanie(PROD:SeacrossPharmaceuticalsLimited,MareaBritanie;) |
| Moldova | (L01CD02) docetaxel | Docetaxel Accord 160 mg/8 ml | N1, 160 mg/8 ml, 8ml, concentrat pentru soluţie perfuzabilă, 160 mg/8 ml , concentrat pentru soluţie perfuzabilă | Ex-factory price without vat |
$0-0 |
$0-0 |
Head and Neck Neoplasms;Carcinoma, Non-Small-Cell Lung;Adenocarcinoma;Prostatic Neoplasms;Breast Neoplasms | AccordHealthcareS.L.U.,Spania(PROD:AccordHealthcarePolskaSp.z.o.o,Polonia;) |
| Moldova | (L01EC01) vemurafenib (adm: O) | Zelboraf® 240 mg | N8x7, 240 mg, comprimate filmate, 240 mg , comprimate filmate | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma | F.Hoffmann-LaRoche,Ltd.,Elveţia(PROD:DelpharmMilanoS.R.L.,Italia;,F.HoffmannLaRocheAG,Elveţia;) |
| Moldova | (L01EE02) cobimetinib (adm: O) | Cotellic® 20 mg | N21x3, 20 mg, comprimate filmate, 20 mg , comprimate filmate | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma | F.Hoffmann-LaRoche,Ltd.,Elveţia(PROD:DelpharmMilanoS.r.l.,Italia;,F.Hoffmann-LaRocheLtd,Elveţia;) |
| Moldova | (L01FA01) rituximab | MabThera® 100 mg/10 ml | N2, 100 mg/10 ml, 10ml, concentrat pentru soluţie perfuzabilă, 100 mg/10 ml , concentrat pentru soluţie perfuzabilă | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Arthritis, Rheumatoid;Leukemia, Lymphocytic, Chronic, B-Cell | F.Hoffmann-LaRoche,Ltd.,Elveţia(PROD:F.Hoffmann-LaRocheLtd,Elveţia;,RocheDiagnosticsGmbH,Germania;) |
| Moldova | (L01FA01) rituximab | MabThera® 500 mg/50 ml | N1, 500 mg/50 ml, 50ml, concentrat pentru soluţie perfuzabilă, 500 mg/50 ml , concentrat pentru soluţie perfuzabilă | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Arthritis, Rheumatoid;Leukemia, Lymphocytic, Chronic, B-Cell | F.Hoffmann-LaRoche,Ltd.,Elveţia(PROD:F.Hoffmann-LaRocheLtd,Elveţia;,RocheDiagnosticsGmbH,Germania;) |
| Moldova | (L01FA03) obinutuzumab (adm: P) | Gazyva® 1000 mg | N1, 1000 mg, 40ml, concentrat pentru soluţie perfuzabilă, 1000 mg , concentrat pentru soluţie perfuzabilă | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | F.Hoffmann-LaRocheLtd,Elveţia(PROD:F.Hoffmann-LaRocheLtd,Elveţia;,RocheDiagnosticsGmbH,Germania;) |
| Moldova | (L01FD01) trastuzumab (adm: P) | Herceptin® 600 mg/5 ml | N1, 600 mg/5 ml, 5ml, soluţie injectabilă, 600 mg/5 ml , soluţie injectabilă | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | F.Hoffmann-LaRoche,Ltd.,Elveţia(PROD:F.Hoffmann-LaRocheLtd,Elveţia;,F.Hoffmann-LaRoche,Ltd.,Elveţia;) |
| Moldova | (L01FD01) trastuzumab (adm: P) | Herceptin® 150 mg | N1, 150 mg, pulbere pentru concentrat pentru soluţie perfuzabilă, 150 mg , pulbere pentru concentrat pentru soluţie perfuzabilă | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | F.Hoffmann-LaRoche,Ltd.,Elveţia(PROD:F.Hoffmann-LaRocheLtd,Elveţia;,RocheDiagnosticsGmbH,Germania;) |
| Moldova | (L01FD02) pertuzumab (adm: P) | Perjeta® 420 mg | N1, 420 mg, 14ml, concentrat pentru soluţie perfuzabilă, 420 mg , concentrat pentru soluţie perfuzabilă | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | F.Hoffmann-LaRoche,Ltd.,Elveţia(PROD:F.Hoffmann-LaRocheLtd,Elveţia;,RocheDiagnosticsGmbH,Germania;) |
| Moldova | (L01FF05) atezolizumab (adm: P) | Tecentriq® 1200 mg/20 ml | N1, 1200 mg/20 ml, 20ml, concentrat pentru soluţie perfuzabilă, 1200 mg/20 ml , concentrat pentru soluţie perfuzabilă | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | F.Hoffmann-LaRoche,Ltd.,Elveţia(PROD:F.Hoffmann-LaRocheLtd,Elveţia;,RocheDiagnosticsGmbH,Germania;) |
Pages
